Comments
Loading...

Regenxbio

RGNXNASDAQ
Logo brought to you by Benzinga Data
$12.53
-0.42-3.24%
At Close: -
$12.53
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$90.00
Lowest Price Target1
$14.00
Consensus Price Target1
$43.79

Regenxbio (NASDAQ:RGNX) Stock, Analyst Ratings, Price Targets, Forecasts

Regenxbio Inc has a consensus price target of $43.79 based on the ratings of 15 analysts. The high is $90 issued by Chardan Capital on November 3, 2021. The low is $14 issued by SVB Leerink on January 23, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Barclays, and HC Wainwright & Co. on September 4, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $42.67 between HC Wainwright & Co., Barclays, and HC Wainwright & Co., there's an implied 240.52% upside for Regenxbio Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Jun
1
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Barclays
Goldman Sachs
Stifel
RBC Capital

1calculated from analyst ratings

Analyst Ratings for Regenxbio

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Regenxbio (RGNX) stock?

A

The latest price target for Regenxbio (NASDAQ:RGNX) was reported by HC Wainwright & Co. on September 4, 2024. The analyst firm set a price target for $39.00 expecting RGNX to rise to within 12 months (a possible 211.25% upside). 19 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Regenxbio (RGNX)?

A

The latest analyst rating for Regenxbio (NASDAQ:RGNX) was provided by HC Wainwright & Co., and Regenxbio reiterated their buy rating.

Q

When was the last upgrade for Regenxbio (RGNX)?

A

The last upgrade for Regenxbio Inc happened on March 8, 2024 when RBC Capital raised their price target to $35. RBC Capital previously had a sector perform for Regenxbio Inc.

Q

When was the last downgrade for Regenxbio (RGNX)?

A

There is no last downgrade for Regenxbio.

Q

When is the next analyst rating going to be posted or updated for Regenxbio (RGNX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Regenxbio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Regenxbio was filed on September 4, 2024 so you should expect the next rating to be made available sometime around September 4, 2025.

Q

Is the Analyst Rating Regenxbio (RGNX) correct?

A

While ratings are subjective and will change, the latest Regenxbio (RGNX) rating was a reiterated with a price target of $39.00 to $39.00. The current price Regenxbio (RGNX) is trading at is $12.53, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch